Literature DB >> 25370179

To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?

Catherine Rongieres1, Carolina Colella, Philippe Lehert.   

Abstract

OBJECTIVE: We assessed the predictive value added by Anti-Mullerian Hormone (AMH) to currently validated live birth (LB) prediction models.
METHODS: Based on recent data from our center, we compared the external validity of the Templeton Model (TM) and its recent improvement (TMA) to select our model of reference. The added predictive value of AMH was assessed in testing the likelihood ratio significance and the Net Reclassification Index (NRI). The surrogate utility of AMH was tested by conducting an exploratory stepwise logistic regression.
RESULTS: Based on 715 cycles, the original TM had poor performances (auROC C = 0.61 [0.58, 0.66], improving by fitting TM to our data (C = 0.71[0.66, 0.75]. TMA fitting proved better (C = 0.76; 95 %CI: 0.71, 0.80) and was selected as model of reference. Adding AMH to TMA or TM had no effect on discrimination (C = 0.76; 95 %CI: 0.72, 0.80), the likelihood ratio test was significant (p = 0.023), but the NRI was not (6.7 %; p = 0.055). A stepwise exploratory logistic regression identified the effects of age, previous IVF resulting in LB, time trend and AMH, leading to a prediction model reduced to four predictors (C = 0.75 [0.70, 0.81]).
CONCLUSION: The added predictive value of AMH is limited. A possible surrogate/simplifying effect of AMH was found in eliminating 9/13 predictors from the model of reference. We conclude that whereas AMH does not add significant predictive value to the existing model, it contributes to simplifying the equation to reliable, easy to collect, and available in all databases predictors: age, AMH, time trend and female previous fertility history.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370179      PMCID: PMC4294874          DOI: 10.1007/s10815-014-0348-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  31 in total

1.  Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.

Authors:  Oybek Rustamov; Alexander Smith; Stephen A Roberts; Allen P Yates; Cheryl Fitzgerald; Monica Krishnan; Luciano G Nardo; Philip W Pemberton
Journal:  Hum Reprod       Date:  2012-07-09       Impact factor: 6.918

Review 2.  AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis.

Authors:  S L Broer; M Dólleman; B C Opmeer; B C Fauser; B W Mol; F J M Broekmans
Journal:  Hum Reprod Update       Date:  2010-07-28       Impact factor: 15.610

3.  Factors that affect outcome of in-vitro fertilisation treatment.

Authors:  A Templeton; J K Morris; W Parslow
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

4.  Templeton prediction model underestimates IVF success in an external validation.

Authors:  L L van Loendersloot; M van Wely; S Repping; F van der Veen; P M M Bossuyt
Journal:  Reprod Biomed Online       Date:  2011-02-20       Impact factor: 3.828

Review 5.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

Review 6.  Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.

Authors:  Jenny A Visser; Izaäk Schipper; Joop S E Laven; Axel P N Themmen
Journal:  Nat Rev Endocrinol       Date:  2012-01-10       Impact factor: 43.330

7.  Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.

Authors:  S Kallio; K Aittomäki; T Piltonen; R Veijola; A Liakka; T E Vaskivuo; L Dunkel; J S Tapanainen
Journal:  Hum Reprod       Date:  2012-01-17       Impact factor: 6.918

8.  Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study.

Authors:  A M E Lintsen; M J C Eijkemans; C C Hunault; C A M Bouwmans; L Hakkaart; J D F Habbema; D D M Braat
Journal:  Hum Reprod       Date:  2007-07-17       Impact factor: 6.918

9.  Comparison of two models predicting IVF success; the effect of time trends on model performance.

Authors:  E R te Velde; D Nieboer; A M Lintsen; D D M Braat; M J C Eijkemans; J D F Habbema; Y Vergouwe
Journal:  Hum Reprod       Date:  2013-11-15       Impact factor: 6.918

10.  Simple adaptations to the Templeton model for IVF outcome prediction make it current and clinically useful.

Authors:  P Arvis; P Lehert; A Guivarc'h-Levêque
Journal:  Hum Reprod       Date:  2012-07-31       Impact factor: 6.918

View more
  2 in total

1.  Reduced Ovarian Function in Female Rheumatoid Arthritis Patients Trying to Conceive.

Authors:  Jenny Brouwer; Radboud J E M Dolhain; Johanna M W Hazes; Jenny A Visser; Joop S E Laven
Journal:  ACR Open Rheumatol       Date:  2019-07-04

2.  Individualized embryo selection strategy developed by stacking machine learning model for better in vitro fertilization outcomes: an application study.

Authors:  Qingsong Xi; Qiyu Yang; Meng Wang; Bo Huang; Bo Zhang; Zhou Li; Shuai Liu; Liu Yang; Lixia Zhu; Lei Jin
Journal:  Reprod Biol Endocrinol       Date:  2021-04-05       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.